Please try another search
Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. It has various therapeutic molecules in the preclinical stage. The company was incorporated in 2015 and is headquartered in Wroclaw, Poland.
Name | Age | Since | Title |
---|---|---|---|
Pawel Holstinghausen Holsten | - | 2018 | Chairman of the Supervisory Board |
Robert Florczykowski | - | 2022 | Independent Member of the Supervisory Board |
Krzysztof Samotij | - | - | Independent Member of the Supervisory Board |
Charles Kunsch | - | 2023 | Member of the Supervisory Board |
Maciej Wroblewski | - | 2021 | Member of the Supervisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review